David Schenkein
InvestorFounderGeneral Partner at GV (Google Ventures) · Board director at Treeline Biosciences · Board director at Denali Therapeutics
Boston, Massachusetts
Writes $250K – $50M checks · typically $25M
About
David Schenkein is a physician-investor, founding Agios CEO who oversaw metabolism‑targeting AML drug approvals, now a general partner who remains a clinician and warns non-dilutive deals can be more dilutive.
Likely emails· guessed from name + firm domain, not firm-published
- d•••@gv.comreveal80% confident
- d•••@gv.comreveal75% confident
Invests in
AI & Machine LearningBiotechConsumerDigital HealthEnterprise SoftwareHealthtechMedical Devices
Board director at Treeline Biosciences
Intro paths
In turn, David can intro founders to Treeline Biosciences's investors below.
Treeline Biosciences's investors · 8
Co-founders at Treeline Biosciences
Board director at Denali Therapeutics
Intro paths
In turn, David can intro founders to Denali Therapeutics's investors below.
Denali Therapeutics's investors · 5
Co-founders at Denali Therapeutics
Experience
- RegeneronBoard Membercurrent2023 — present
- GVGeneral Partnercurrent2019 — presentGreater Boston Area
- Tufts Medical CenterClinical Professor of Medicinecurrent2009 — present
- Denali TherapeuticsBoard Membercurrent2015 — present
- Agios PharmaceuticalsBoard Member2009 — 2025
- Agios PharmaceuticalsChairperson of the Board2019 — 2022
- Agios PharmaceuticalsCEO2009 — 2019
- GenentechSenior Vice President, Clinical Hematology/Oncology2006 — 2009
- Millennium PharmaceuticalsSenior Vice President, Clinical Research2001 — 2006
Education
- Wesleyan UniversityBachelor of Arts (B.A.), Chemistry1975 — 1979
- Upstate Medical UniversityDoctor of Medicine (M.D.)1979 — 1983
Deals · 2
Treeline BiosciencesBoard seat
via GV (Google Ventures) · filed Sep 2025 · $250M raise
Denali TherapeuticsBoard seat
via GV (Google Ventures) · filed Mar 2024 · $499.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Aera TherapeuticsAgios PharmaceuticalsLeyden LabsPrime Medicine
Investor
Accent TherapeuticsArda TherapeuticsDelphia TherapeuticsEncoded TherapeuticsIconOVir BioKronos BioMestag TherapeuticsMonte Rosa TherapeuticsOblenio BioParadigm HealthPelage PharmaceuticalsPretzel TherapeuticsResilienceRhyGaze
Sources: the firm's website · SEC Form D filings.
Colleagues at GV (Google Ventures)
Network11
Investors connected to David in public investor directories — a warm-intro map.
Frequently asked questions
- Who is David Schenkein?
- David Schenkein is a physician-investor, founding Agios CEO who oversaw metabolism‑targeting AML drug approvals, now a general partner who remains a clinician and warns non-dilutive deals can be more dilutive.
- Where does David Schenkein work?
- David Schenkein is General Partner at GV (Google Ventures) and Board director at Treeline Biosciences and Board director at Denali Therapeutics.
- What does David Schenkein invest in?
- David Schenkein invests in AI & Machine Learning, Biotech, Consumer, Digital Health, Enterprise Software, Healthtech, Medical Devices.
- What check size does David Schenkein write?
- David Schenkein typically writes checks of $250K – $50M.
- What boards does David Schenkein sit on?
- David Schenkein holds tracked board seats at Aera Therapeutics, Agios Pharmaceuticals, Denali Therapeutics, Denali Therapeutics, Leyden Labs, Prime Medicine, Treeline Biosciences, Treeline Biosciences.
- What companies has David Schenkein invested in?
- Investments tracked here include Accent Therapeutics, Arda Therapeutics, Delphia Therapeutics, Encoded Therapeutics, IconOVir Bio, Kronos Bio, Mestag Therapeutics, Monte Rosa Therapeutics, Oblenio Bio, Paradigm Health, Pelage Pharmaceuticals, Pretzel Therapeutics, and 2 more.
- Where did David Schenkein go to school?
- David Schenkein studied at Wesleyan University (Bachelor of Arts (B.A.), Chemistry); Upstate Medical University (Doctor of Medicine (M.D.)).
Founder mafias
Wesleyan University mafia13
Also came through, then founded or led a company.
+ 6 more
GV (Google Ventures) mafia3
Also came through, then founded or led a company.
Same school
Also attended Wesleyan University61
+ 55 more
Also attended Upstate Medical University1
Shared employers
Also worked at Regeneron17
+ 11 more
